Test ID: FRTLP
T-Cell Lymphoma, FISH, Blood or Bone Marrow
Secondary ID
A test code used for billing and in test definitions created prior to November 2011
NY State Approved
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Useful For
Suggests clinical disorders or settings where the test may be helpful
Detecting a neoplastic clone associated with the common chromosome anomalies seen in patients with various T-cell lymphomas
Tracking known chromosome anomalies and response to therapy in patients with T-cell lymphoma
Reflex Tests
Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| ADD1F | One Additional FISH Probe | No | No |
| ADD2F | Two Additional FISH Probes | No | No |
| ADD4F | Four Additional FISH Probes | No | No |
| ADD3F | Three Additional FISH Probes | No | No |
| ADD5F | Five Additional FISH Probes | No | No |
| ADD6F | Six Additional FISH Probes | No | No |
| ADD7F | Seven Additional FISH Probes | No | No |
| ADD8F | Eight Additional FISH Probes | No | No |
| ADD9F | Nine Additional FISH Probes | No | No |
| ADD10 | Ten Additional FISH Probes | No | No |
| ADD11 | Eleven Additional FISH Probes | No | No |
| ADD12 | Twelve Additional FISH Probes | No | No |
| 14FP | Fourteen Additional FISH Probes | No | No |
| 13FP | Thirteen Additional FISH Probes | No | No |
| 15FP | Fifteen Additional FISH Probes | No | No |
| 16FP | Sixteen Additional FISH Probes | No | No |
| 17FP | Seventeen Additional FISH Probes | No | No |
| 18FP | Eighteen Additional FISH Probes | No | No |
| 19FP | Nineteen Additional FISH Probes | No | No |
| 20FP | Twenty Additional FISH Probes | No | No |
| 21FP | Twenty One Additional FISH Probes | No | No |
| 22FP | Twenty Two Additional FISH Probes | No | No |
| 23FP | Twenty Three Additional FISH Probes | No | No |
| 24FP | Twenty Four Additional FISH Probes | No | No |
| 25FP | Twenty Five Additional FISH Probes | No | No |
| 26FP | Twenty Six Additional FISH Probes | No | No |
| 27FP | Twenty Seven Additional FISH Probes | No | No |
| 28FP | Twenty Eight Additional FISH Probes | No | No |
| 29FP | Twenty Nine Additional FISH Probes | No | No |
| 30FP | Thirty Additional FISH Probes | No | No |
Testing Algorithm
Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
This panel includes testing for the following anomalies via the probes listed:
t(14;var)(q32.1;var), TCL1A
-7/7q-/i(7q), D7S486/Cen7
+8, Cen8/MYC
If the patient is being tracked for known anomalies, indicate which anomalies need to be investigated.
When this test is ordered, a charge for 2 FISH probes and interpretation is included. If additional probes or the entire panel are ordered, additional probe charges will be added.
See Malignant Lymphoma, Guideline for Bone Marrow Staging Studies in Special Instructions
Special Instructions and Forms
Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name
A short description of the method used to perform the test
Fluorescence In Situ Hybridization (FISH)
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Aliases
Lists additional common names for a test, as an aid in searching
del(7q)
Deletion 7
Hepatosplenic T-Cell Lymphoma
Inv(14)
Inversion(14)
Iso7q
Prolymphocytic Leukemia (PLL)
TCL1A
Trisomy 8
Specimen Type
Describes the specimen type needed for testing
Specimen Required
Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
Provide a reason for referral with each specimen. The laboratory will not reject testing if this information is not provided, but appropriate testing and interpretation may be compromised or delayed.
Forms:
1. Cytogenetics Hematologic FISH Panel Patient Information Sheet (Supply T603) in Special Instructions
2. If not ordering electronically, submit a Cytogenetics Hematologic Disorders Request Form (Supply T607) with the specimen.
Advise Express Mail or equivalent if not on courier service.
Submit only 1 of the following specimens:
Preferred:
Specimen Type: Blood
Container/Tube: Green top (sodium heparin)
Specimen Volume: 7-10 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Other anticoagulants are not recommended and are harmful to the viability of the cells.
Specimen Type: Bone marrow
Container/Tube: Green top (sodium heparin)
Specimen Volume: 1-2 mL
Collection Instructions:
1. Invert several times to mix bone marrow.
2. Other anticoagulants are not recommended and are harmful to the viability of the cells.
Specimen Minimum Volume
Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
| Hemolysis | NA |
| Lipemia | NA |
| Icterus | NA |
| Other | Clotted blood or bone marrow |
Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Ambient (preferred) | |
| Refrigerated | ||
Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
T-cell neoplasms are relatively uncommon, accounting for approximately 12% of all non-Hodgkin lymphomas. There are several subtypes of T-cell neoplasms: T-cell acute lymphoblastic leukemia (T-ALL), T-cell prolymphocytic leukemia (T-PLL), T-cell large granular lymphocytic leukemia (T-LGL), anaplastic large cell lymphoma (ALCL), peripheral T-cell lymphoma, and various other cutaneous, nodal, and extranodal lymphoma subtypes. The 2 most prevalent lymphoma subtypes are unspecified peripheral T-cell lymphoma (3.7%) and ALCL (2.4%). T-cell neoplasms are among the most aggressive of all hematologic and lymphoid neoplasms with the exception of ALCL, which is usually responsive to chemotherapy.
There are a few common chromosome anomalies associated with specific subtypes, which this FISH test can detect:
-inv(14)(q11q32) and t(14;14)(q11;q32), which involve the T-cell leukemia/lymphoma 1 gene (TCL1A) and have been associated with T-PLL
-Isochromosome 7q and trisomy 8, which have been associated with hepatosplenic T-cell lymphoma
These probes have diagnostic relevance and can also be used to track response to therapy.
This assay detects chromosome abnormalities observed in the blood and bone marrow of patients with T-cell lymphoma (for patients with T-cell acute leukemia, see FRTAL/88783 T-Cell Acute Lymphoblastic Leukemia [T-ALL], FISH).
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
An interpretive report will be provided.
Interpretation
Provides information to assist in interpretation of the test results
A neoplastic clone is detected when the percent of cells with an abnormality exceeds the normal reference range for any given probe.
Detection of an abnormal clone supports a diagnosis of a T-cell lymphoma. The specific anomaly detected may help subtype the neoplasm.
The absence of an abnormal clone does not rule out the presence of neoplastic disorder.
Cautions
Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances
This test should not be ordered on patients with T-cell acute lymphoblastic leukemia. In these situations, see FRTAL/88783 T-Cell Acute Lymphoblastic Leukemia (T-ALL), FISH.
This test is not FDA-approved; and it is best used as an adjunct to existing clinical and pathologic information.
Clinical Reference
Provides recommendations for further in-depth reading of a clinical nature
1. World Heath Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Edited by ES Jaffe, NL Harris, H Stein, JW Vardiman. Lyon, IARC Press, 2001
2. Gesk S, Martin-Subero JI, Harder L, et al: Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 2003;17:738-745
3. Chin M, Mugishima H, Takamura M, et al: Hemophagocytic syndrome and hepatosplenic (gamma)(delta) T-cell lymphoma with isochromosome 7q and 8 trisomy. J Pediatr Hematol Oncol 2004;26(6):375-378
Method Description
Describes how the test is performed and provides a method-specific reference
Anomalies involving TCL1 are detected using a break-apart FISH probe. Trisomy of chromosome 8 and isochromosome 7q are detected using enumeration strategies. A combination of commercially available and Mayo in-house developed FISH probes are utilized. For each probe set, 200 interphase nuclei are scored and results for each abnormal probe is expressed as percent abnormal nuclei. (Unpublished Mayo method)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Samples processed Monday through Sunday. Results reported Monday through Friday, 8 a.m.-5 p.m. CST.
Analytic Time
Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
Maximum Laboratory Time
Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
Specimen Retention Time
Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Performing Laboratory Location
The location of the laboratory that performs the test
Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
T-Cell Lymphoma, FISH, Blood or Bone Marrow
88271 x 2-DNA probe, each
88275 x 2-Interphase in situ hybridization
88291-Interpretation and report
One Additional FISH Probe
88271-DNA probe, each (if appropriate)
88275-Interphase in situ hybridization (if appropriate)
Two Additional FISH Probes
88271 x 2-DNA probe, each (if appropriate)
88275-Interphase in situ hybridization (if appropriate)
Three Additional FISH Probes
88271 x 3-DNA probe, each (if appropriate)
88275-Interphase in situ hybridization (if appropriate)
Four Additional FISH Probes
88271 x 4-DNA probe, each (if appropriate)
88275 x 2-Interphase in situ hybridization (if appropriate)
Five Additional FISH Probes
88271 x 5-DNA probe, each (if appropriate)
88275 x 2-Interphase in situ hybridization (if appropriate)
Six Additional FISH Probes
88271 x 6-DNA probe, each (if appropriate)
88275 x 3-Interphase in situ hybridization (if appropriate)
Seven Additional FISH Probes
88271 x 7-DNA probe, each (if appropriate)
88275 x 3-Interphase in situ hybridization (if appropriate)
Eight Additional FISH Probes
88271 x 8-DNA probe, each (if appropriate)
88275 x 4-Interphase in situ hybridization (if appropriate)
Nine Additional FISH Probes
88271 x 9-DNA probe, each (if appropriate)
88275 x 4-Interphase in situ hybridization (if appropriate)
Ten Additional FISH Probes
88271 x 10-DNA probe, each (if appropriate)
88275 x 5-Interphase in situ hybridization (if appropriate)
Eleven Additional FISH Probes
88271 x 11-DNA probe, each (if appropriate)
88275 x 5-Interphase in situ hybridization (if appropriate)
Twelve Additional FISH Probes
88271 x 12-DNA probe, each (if appropriate)
88275 x 6-Interphase in situ hybridization (if appropriate)
Thirteen Additional FISH Probes
88271 x 13-DNA probe, each (if appropriate)
88275 x 6-Interphase in situ hybridization (if appropriate)
Fourteen Additional FISH Probes
88271 x 14-DNA probe, each (if appropriate)
88275 x 7-Interphase in situ hybridization (if appropriate)
Fifteen Additional FISH Probes
88271 x 15-DNA probe, each (if appropriate)
88275 x 7-Interphase in situ hybridization (if appropriate)
Sixteen Additional FISH Probes
88271 x 16-DNA probe, each (if appropriate)
88275 x 8-Interphase in situ hybridization (if appropriate)
Seventeen Additional FISH Probes
88271 x 17-DNA probe, each (if appropriate)
88275 x 8-Interphase in situ hybridization (if appropriate)
Eighteen Additional FISH Probes
88271 x 18-DNA probe, each (if appropriate)
88275 x 9-Interphase in situ hybridization (if appropriate)
Nineteen Additional FISH Probes
88271 x 19-DNA probe, each (if appropriate)
88275 x 9-Interphase in situ hybridization (if appropriate)
Twenty Additional FISH Probes
88271 x 20-DNA probe, each (if appropriate)
88275 x 10-Interphase in situ hybridization (if appropriate)
Twenty One Additional FISH Probes
88271 x21-DNA probe, each (if appropriate)
88275 x10-Interphase in situ hybridization (if appropriate)
Twenty Two Additional FISH Probes
88271 x22-DNA probe, each (if appropriate)
88275 x11-Interphase in situ hybridization (if appropriate)
Twenty Three Additional FISH Probes
88271 x23-DNA probe, each (if appropriate)
88275 x11-Interphase in situ hybridization (if appropriate)
Twenty Four Additional FISH Probes
88271 x24-DNA probe, each (if appropriate)
88275 x12-Interphase in situ hybridization (if appropriate)
Twenty Five Additional FISH Probes
88271 x25-DNA probe, each (if appropriate)
88275 x12-Interphase in situ hybridization (if appropriate)
Twenty Six Additional FISH Probes
88271 x26-DNA probe, each (if appropriate)
88275 x13-Interphase in situ hybridization (if appropriate)
Twenty Seven Additional FISH Probes
88271 x27-DNA probe, each (if appropriate)
88275 x13-Interphase in situ hybridization (if appropriate)
Twenty Eight Additional FISH Probes
88271 x28-DNA probe, each (if appropriate)
88275 x14-Interphase in situ hybridization (if appropriate)
Twenty Nine Additional FISH Probes
88271 x29-DNA probe, each (if appropriate)
88275 x14-Interphase in situ hybridization (if appropriate)
Thirty Additional FISH Probes
88271 x30-DNA probe, each (if appropriate)
88275 x15-Interphase in situ hybridization (if appropriate)
LOINC® Code Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
| Result ID | Reporting Name | LOINC Code |
|---|---|---|
| 27587 | Specimen | 31208-2 |
| 27588 | Specimen ID | N/A |
| G_953 | Source | N/A |
| 27590 | Order Date | N/A |
| G_955 | Reason For Referral | 42349-1 |
| 27592 | Method | In Process |
| 27593 | Result | In Process |
| 27594 | Interpretation | 69965-2 |
| 27595 | Amendement | In Process |
| 27596 | Reviewed By: | N/A |
| 27597 | Release Date | N/A |


